Abstract CT109: A first-in-human phase 1 study of LY4050784, an oral, potent, and selective SMARCA2 inhibitor, in patients with advanced solid tumors with SMARCA4 alterations (Trial in Progress)

Timothy Yap; Alexander Spira; Adam Schoenfeld; Vivek Subbiah; Alexander Philipovskiy; Benjamin O. Herzberg; Gerald Falchook; Ibiayi Dagogo-Jack; Christine M. Bestvina; Shigehisa Kitano; Haruyasu Murakami; Tejas Patil; Gilberto Lopes; Amy E. Chang; Binoj C. Nair; Chunxiao Wang; Tatsuya Yoshida

doi:10.1158/1538-7445.AM2025-CT109

Back

Abstract CT109: A first-in-human phase 1 study of LY4050784, an oral, potent, and selective SMARCA2 inhibitor, in patients with advanced solid tumors with SMARCA4 alterations (Trial in Progress)

Journal article

Peer reviewed

Abstract CT109: A first-in-human phase 1 study of LY4050784, an oral, potent, and selective SMARCA2 inhibitor, in patients with advanced solid tumors with SMARCA4 alterations (Trial in Progress)

Timothy Yap, Alexander Spira, Adam Schoenfeld, Vivek Subbiah, Alexander Philipovskiy, Benjamin O. Herzberg, Gerald Falchook, Ibiayi Dagogo-Jack, Christine M. Bestvina, Shigehisa Kitano, …

Cancer research (Chicago, Ill.), Vol.85(8_Supplement_2), pp.CT109-CT109

2025-04-25

DOI: https://doi.org/10.1158/1538-7445.AM2025-CT109

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details

Title: Abstract CT109: A first-in-human phase 1 study of LY4050784, an oral, potent, and selective SMARCA2 inhibitor, in patients with advanced solid tumors with SMARCA4 alterations (Trial in Progress)
Creators: Timothy Yap - The University of Texas MD Anderson Cancer Center
Alexander Spira - Virginia Cancer Specialists
Adam Schoenfeld - Memorial Sloan Kettering Cancer Center
Vivek Subbiah - Sarah Cannon
Alexander Philipovskiy - Sarah Cannon
Benjamin O. Herzberg - Columbia University Irving Medical Center
Gerald Falchook - Sarah Cannon
Ibiayi Dagogo-Jack - Massachusetts General Hospital
Christine M. Bestvina - University of Chicago
Shigehisa Kitano - Japanese Foundation For Cancer Research
Haruyasu Murakami - Shizuoka Cancer Center
Tejas Patil - University of Colorado Denver
Gilberto Lopes - University of Miami
Amy E. Chang - Eli Lilly
Binoj C. Nair - Eli Lilly
Chunxiao Wang - Eli Lilly
Tatsuya Yoshida - Tokyo National Hospital
Publication Details: Cancer research (Chicago, Ill.), Vol.85(8_Supplement_2), pp.CT109-CT109
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032661999502976